Related Experiment Videos
Splanchnic transplantation. An approach to the infant dependent on parenteral nutrition who develops irreversible
J W Williams1, H N Sankary, P F Foster
1Department of General Surgery, Rush-Presbyterian-St Luke's Medical Center, Chicago, Ill 60612.
Insights
Composite splanchnic transplantation offers a viable solution for infants with short-bowel syndrome and liver failure. However, this life-saving procedure is associated with a high incidence of lymphoma, necessitating further research into prevention strategies.
Area of Science:
- Pediatric Surgery
- Transplantation Immunology
- Gastroenterology
Background:
- Short-bowel syndrome and liver failure in infants often necessitate parenteral nutrition, carrying significant risks.
- Composite splanchnic allografts (liver, stomach, duodenum, pancreas, jejunum, ileum) offer a potential solution for complex cases.
Observation:
- Two infants with short-bowel syndrome and liver failure underwent en bloc composite splanchnic transplantation.
- Initial complications were managed, leading to near-normal function of the allograft in the second case.
- A monoclonal, malignant, B-cell lymphoproliferative disorder developed in the recipient.
Findings:
- Composite splanchnic transplantation is feasible in metabolically compromised infants.
- Intestinal allograft rejection is manageable with current immunosuppressive therapies.
- The procedure is associated with a high incidence of post-transplant lymphoproliferative disorder (PTLD).
Implications:
- Composite splanchnic transplantation is a viable therapeutic option for severe infantile gastrointestinal and liver failure.
- Future research must focus on mitigating the risk of PTLD following this complex procedure.
- Developing strategies to prevent PTLD is crucial for the long-term success of intestinal transplantation.
Abstract:
Two infants with short-bowel syndrome and liver failure associated with obligatory parenteral nutrition received a composite allograft that consisted of en bloc liver, stomach, duodenum, pancreas, jejunum, and ileum. Solutions to the fatal complications in the first case resulted in a functioning composite splanchnic system in the second case. Despite a number of early complications, the small intestine and liver developed near-normal function until a monoclonal, malignant, B-cell lymphoproliferative disorder appeared. The analysis of these two cases supports three summary observations: the operative procedure can be safely performed in a metabolically compromised infant; intestinal allograft rejection, in this model, is controllable with existing immunosuppressive drugs; and this procedure appears to be associated with a uniquely high incidence of lymphoma. Since transplantation is a feasible solution to this devastating infantile disease, further development of this therapy must incorporate means of preventing lymphoma.